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he adaptor protein (AP) 3 adaptor complex has been
implicated in the transport of lysosomal membrane
proteins, but its precise site of action has remained
controversial. Here, we show by immuno-electron micros-
copy that AP-3 is associated with budding profiles evolving
from a tubular endosomal compartment that also exhibits
budding profiles positive for AP-1. AP-3 colocalizes with
clathrin, but to a lesser extent than does AP-1. The AP-3– and
AP-1–bearing tubular compartments contain endocytosed
transferrin, transferrin receptor, asialoglycoprotein receptor,
and low amounts of the cation-independent mannose
T
 
6-phosphate receptor and the lysosome-associated mem-
brane proteins (LAMPs) 1 and 2. Quantitative analysis re-
vealed that of these distinct cargo proteins, only LAMP-1
and LAMP-2 are concentrated in the AP-3–positive membrane
domains. Moreover, recycling of endocytosed LAMP-1 and
CD63 back to the cell surface is greatly increased in AP-3–
deficient cells. Based on these data, we propose that AP-3
defines a novel pathway by which lysosomal membrane
proteins are transported from tubular sorting endosomes
to lysosomes.
 
Introduction
 
Heterotetrameric adaptor complexes play a role in the selec-
tion of cargo molecules and vesicle budding. In mammalian
cells, there are at least four adaptor protein (AP) com-
plexes (AP-1 through AP-4), each of which mediates a dis-
tinct membrane trafficking step (Robinson and Bonifacino,
2001). Adaptor complexes consist of four subunits: two large
subunits (the so-called 
 

 
 subunit and the more divergent 
 

 
/
 

 
/
 

 
/
 

 
 subunit in AP-1/2/3/4, respectively), a medium subunit
(
 

 
), and a small subunit (
 

 
). The structure of the adaptor
complexes resembles that of a “Mickey Mouse” head,
with the COOH-terminal domains of the two large subunits
protruding like ears (Heuser and Keen, 1988).
Although the AP-3 adaptor complex was identified relatively
recently, a considerable amount of functional information
has already been acquired, thanks to the availability of
naturally occurring mutants. Loss of functional AP-3 complex
leads to defects in the function of lysosomes and lysosome-
related organelles. The most obvious trafficking defect in
AP-3–deficient cells is that integral lysosomal membrane
proteins (also known as lysosomal glycoproteins), including
lysosome-associated membrane proteins (LAMPs) 1 and 2,
LIMP-2, CD63, and CD1, show increased trafficking via
the plasma membrane (Dell’Angelica et al., 1999; Rous et
al., 2002; Sugita et al., 2002). Nevertheless, their steady-
state distribution is still mainly lysosomal. Mannose 6-phos-
phate receptor–based transport of soluble lysosomal enzymes
and cycling of the transferrin receptor (TfR) between the
plasma membrane and endosomes are independent of AP-3
function (Le Borgne et al., 1998; Dell’Angelica et al., 1999).
Despite the accumulating evidence implicating AP-3 in
the intracellular transport of lysosomal membrane proteins,
the transport step that is mediated by AP-3 has remained
unclear. In yeast, like in mammalian cells, AP-3 deletion
leads to the missorting of the vacuolar membrane proteins
alkaline phosphate and Vam3p, but does not affect the
trafficking of Vps10p, the receptor for the soluble hydrolase
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carboxypeptidase Y (Cowles et al., 1997; Stepp et al., 1997).
By contrast, yeast VPS mutants are still able to sort vacuolar
membrane proteins to the vacuole. Hence, it was proposed
that in yeast, AP-3 mediates a direct pathway for vacuolar
membrane proteins from the TGN to the vacuole (Odorizzi
et al., 1998). In mammalian cells, immunofluorescence lo-
calization experiments of the AP-3 complex have revealed
concentrated staining in the perinuclear region, partially
overlapping with markers of the TGN, but also significant
staining out in the cell periphery, partially colocalizing with
endocytic markers such as TfR (Simpson et al., 1996, 1997;
Dell’Angelica et al., 1997, 1999). The degree of overlap with
either TGN or endosomal markers varied considerably be-
tween these experiments. EM localization analyses also indi-
cated a dual localization of the AP-3 complex on the TGN,
as well as on endosomes (Simpson et al., 1996; Dell’Angelica
et al., 1998).
At present, two (not mutually exclusive) models have been
proposed to explain the role of the AP-3 complex in lysoso-
mal membrane protein trafficking in mammalian cells (for
review see Starcevic et al., 2002). In the first model, as in
yeast, AP-3 is proposed to be responsible for recruiting lyso-
somal membrane proteins into a direct transport pathway
from the TGN to endosomes/lysosomes. Lack of AP-3 func-
tion would then result in increased amounts of newly syn-
thesized proteins traveling from the TGN via the constitu-
tive pathway to the plasma membrane, from where it would
be internalized by AP-2–dependent endocytosis and subse-
quently transported to the lysosomes. The second model
proposes that AP-3 functions at an early endosomal com-
partment in which lysosomal membrane proteins must be
segregated from other membrane proteins that recycle back
to the plasma membrane. Lack of functional AP-3 would
then lead to a buildup on the plasma membrane and in the
recycling system.
The role of clathrin in AP-3 function has also remained
controversial. Two isoforms of the AP-3 
 

 
 subunit are
known, the ubiquitous 
 

 
3A and the neuro (endocrine)-spe-
cific 
 

 
3B, both of which contain a clathrin consensus-bind-
ing motif (Dell’Angelica et al., 1998; ter Haar et al., 2000).
Biochemical analyses have shown that AP-3 can bind and re-
cruit clathrin in vitro onto synthetic liposomes (Dell’Angel-
ica et al., 1998; Drake et al., 2000). However, unlike AP-1
and AP-2, the AP-3 complex is not enriched in purified
clathrin-coated vesicles (Simpson et al., 1996; unpublished
data), and genetic and biochemical evidence suggest that the
AP-3 complex does not require clathrin for function in vivo
(Vowels and Payne, 1998; Wettey et al., 2002). Moreover,
AP-3–deficient mammalian cells were shown to be rescued
almost as well by a 
 

 
3A construct lacking the consensus
clathrin-binding site as by the wild-type construct, suggest-
ing that clathrin binding to the 
 

 
3A subunit of the AP-3 is
not required for AP-3 function (Peden et al., 2002). Im-
muno-colocalization analyses of clathrin and AP-3 have also
produced conflicting results (Simpson et al., 1996; Dell’An-
gelica et al., 1998; Peden et al., 2002). Thus, whether or not
clathrin is required for AP-3 function still remains unclear.
To address these key questions on AP-3 function, we have
generated an mAb against the 
 

 
 subunit of the AP-3 com-
plex, and have used this antibody to localize AP-3 by im-
muno-EM. This approach offers the unique possibility of lo-
calizing AP-3 in direct comparison to lysosomal membrane
proteins, as well as with other cargo and coat proteins, at
a resolution sufficient to define small membrane micro-
domains involved in protein sorting. Our results provide
evidence for the function of the AP-3 complex in the traf-
ficking of lysosomal membrane proteins from endosomes,
whereas no support for a role at the TGN was found. Unex-
pectedly, our data indicate that the endosomal AP-3 path-
way arises from early endosome (EE)–associated tubules
rather than the endosomal vacuole, implicating tubular en-
dosomes also involved in protein recycling as an important
intermediate station in lysosomal membrane protein traffic
to the lysosomes.
 
Results
 
Generation of mAbs against the 
 

 
 subunit of AP-3
 
To investigate the localization of the AP-3 adaptor complex,
it was necessary to generate antibodies that are suitable for
immuno-EM experiments. To this end, we immunized mice
with a GST fusion protein containing the hinge region (aa
608–800) of the 
 

 
 subunit, as this region is the most immu-
nogenic (Fig. S1 A, available at http://www.jcb.org/cgi/
content/full/jcb.200311064/DC1). After fusion, the super-
natants from the resulting hybridomas were screened by
ELISA. Then, Western blotting and immunofluorescence
was performed on both control and 
 
mocha
 
 fibroblasts (
 

 
 defi-
cient) to confirm their specificity. SA4, the monoclonal used
in this work, did not yield a Western or immunofluorescence
signal in the 
 
mocha
 
 extracts or cells, confirming that the anti-
body is specific for the 
 

 
 subunit and does not cross react
with any other proteins (Fig. S1, B and C). Moreover, the
monoclonal gives the characteristic staining pattern for AP-3
of punctate spots throughout the cytoplasm (Fig. S1 C).
 
Immuno-EM localization of the AP-3 complex 
on EE-associated tubules
 
To investigate the localization of the AP-3 adaptor complex
in subcellular detail, ultrathin cryosections were prepared
from HepG2 and normal rat kidney (NRK) cells, and
were immunogold labeled with the different anti-
 

 
-subunit
mAbs. Significant specific immunogold labeling was ob-
tained with several anti-AP-3 monoclonals, but SA4 was se-
lected for this work as it gave the highest labeling efficiency,
especially in cells fixed only with formaldehyde. Although
we obtained a similar staining pattern for AP-3 in both cell
lines, we concentrated on HepG2 cells because they exhib-
ited stronger staining.
First, we addressed whether AP-3 resides on the TGN
and/or on endosome-associated membranes. The tubular
membrane network within a distance of 
 

 
500 nm from the
trans-most cisternae of a Golgi stack was considered as TGN
(Geuze et al., 1985). These membranes are enriched in cat-
ion-independent mannose 6-phosphate receptor (CI-MPR;
Fig. 1) and TGN46 (unpublished data), and show clathrin-
coated and AP-1–coated buds at their cytoplasmic surface
(Fig. 1 A) that mediate the exit of CI-MPR from the TGN
to the endosomes (Klumperman et al., 1993; Doray et al.,
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2002; Waguri et al., 2003). The average diameter of the CI-
MPR and AP-1–positive buds on the TGN was 77 nm (
 
n
 
 
 

 
42). No significant AP-3 labeling was found in these TGN
profiles (Fig. 1, B–D).
By contrast, AP-3 was present on highly convoluted tu-
bules that were often found in close vicinity to endosomal
vacuoles (Fig. 1 C and Fig. 2). On these tubules, AP-3 was
associated with buds that were significantly smaller than
those on the TGN, i.e., only 33 nm (
 
n
 
 
 

 
 40; Fig. 2, A–E).
The AP-3–positive tubules were reminiscent of the EE recy-
cling tubules as described by others (Geuze et al., 1983;
Marsh et al., 1986; Griffiths et al., 1989). Therefore, to as-
say the nature of these tubules, we performed colocalization
experiments with internalized transferrin (Tf) and asialogly-
coprotein receptor (ASGPR), both markers of the endoso-
mal recycling pathway. After a 20-min internalization, biotin-
ylated Tf (Tf-biotin) was found at the limiting membrane of
EE vacuoles, as well as in the associated tubules (Fig. 2, A
and B). By double labeling, we found AP-3–positive buds
on the Tf-biotin–containing recycling tubules. Similar re-
sults were obtained when cells were double labeled for AP-3
and endogenous ASGPR (Fig. 2, C and D). Primary en-
docytic vesicles labeled with the endocytic tracer BSA-gold
were consistently devoid of AP-3 label (unpublished data).
AP-3–positive tubules also contained small amounts of CI-
MPR (Fig. 2 E). The CI-MPR label was mostly found dis-
persed in the noncoated areas of the AP-3–positive tubules,
but occasionally AP-3–negative buds were observed where
CI-MPR was concentrated (Fig. 2, F and G; arrowheads).
Together, these findings show that AP-3 resides on a tubular
endosomal compartment that contains cargo proteins des-
tined for recycling to the plasma membrane or the TGN.
 
AP-3 localizes to clathrin-coated membranes
 
Previous reports have not clearly resolved whether AP-3 uses
clathrin as its structural scaffold in vivo. Therefore, we per-
formed double labelings of AP-3 and clathrin (Fig. 3, A and
B). AP-3 was found on membranes that were (Fig. 3 A) and
were not (Fig. 3 B) labeled for clathrin. Moreover, AP-3–
positive buds were also seen on tubules that displayed clath-
Figure 1. AP-3 is not found in the TGN of HepG2 
cells. (A) In HepG2 cells, CI-MPR (10-nm gold) 
and AP-1 (15-nm gold) colocalize on membranes 
at the trans-side of the Golgi complex, indicating 
the position of the TGN. Some TGN membranes 
typically contain elongated stretches of clathrin 
(top row of arrowheads). The AP-1– and CI-MPR–
labeled budding profiles in the TGN (bottom two 
arrowheads) are considerably wider than AP-3–
labeled profiles (B–D, arrows). (B–D) AP-3 (15-nm 
gold) is not found on membranes in the TGN area, 
but on tubulo-vesicular profiles dispersed in the 
cytoplasm (B and D, arrows) or near endosomal 
vacuoles (C, arrows). E, endosome; G, Golgi 
complex; L, lysosome; M, mitochondrion; P, plasma 
membrane. Bars, 200 nm.
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rin-coated buds not labeled for AP-3 (Fig. 3 B). This
prompted us to investigate whether different APs may asso-
ciate with distinct buds of a continuous endosomal tubule.
Indeed, double labeling of AP-3 and AP-1 in HepG2 cells
revealed that these two coat complexes could be found on
distinct buds arising from a single, continuous tubular mem-
brane (Fig. 3 C). By triple labeling, the presence of internal-
ized Tf-biotin was shown in the tubular membranes dis-
playing AP-1– and AP-3–positive buds, confirming their
endosomal origin (Fig. 3 D). Similar observations were
Figure 2. Ultrathin cryosections of HepG2 cells 
showing the presence of AP-3 on membrane buds 
evolving from EE-associated tubules. (A and B) 
HepG2 cells were incubated with Tf-biotin for 20 
min to define early endosomes (EEs). Sections were 
double labeled for AP-3 (15-nm gold) and biotin 
(10-nm gold). AP-3 colocalizes with Tf-biotin in 
the recycling tubules (arrows) that emerge from the 
EE vacuoles. Note that AP-3 labeling is restricted to 
tubular endings and budding profiles on the tubules. 
(C) HepG2 cells were loaded for 60 min with BSA 
5-nm gold, which marks the lysosomal pathway 
and is absent from recycling tubules. AP-3 (15-nm 
gold) is found on recycling tubules containing 
ASGPR (10-nm gold, arrows). (D) Labeling as in C, 
but in the absence of internalized BSA-gold. AP-3 
is localized to buds that evolve from EE-associated 
recycling tubules containing ASGPR (arrows). 
(E–G) AP-3 (15-nm gold) and CI-MPR (10-nm gold). 
(E) Low labeling densities of CI-MPR are present in 
endosome (E)-associated tubules with AP-3–positive 
buds (arrow). (F and G) Occasionally, CI-MPR label 
is seen concentrated in budding profiles (arrow-
heads) that are not labeled for AP-3 (arrows). 
Bars, 200 nm.
Figure 3. AP-3–positive buds partially colocalize 
with clathrin, whereas AP-3 and AP-1 localize to 
distinct buds evolving from a single endosomal 
tubule. (A and B) HepG2 cells double labeled for 
AP-3 (10-nm gold) and clathrin (15-nm gold). 
Arrows point to AP-3–positive buds that are also 
stained for clathrin. Open arrowheads mark 
membrane profiles labeled for AP-3 only. Closed 
arrowheads denote clathrin labeling only. (C) HepG2 
cells double labeled for AP-3 (15-nm gold, arrow) 
and AP-1 (10-nm gold, arrowhead), showing that 
the two adaptor complexes are present on distinct 
buds of a continuous tubule. (D) Similar labeling 
as in A, but in addition the presence of internalized 
Tf-biotin (for 20 min at 37	C) is indicated by 5-nm 
gold, unequivocally defining the endosomal origin 
of this tubule. (E) NRK cells. Labeling as in A. 
Bars, 200 nm.
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made in NRK cells (Fig. 3 E). The average size of AP-1 buds
on endosomal tubules was 43 nm (
 
n
 
 
 

 
 37), which is consid-
erably smaller than AP-1 buds in the TGN (77 nm) and in
the same range as the AP-3 buds (33 nm). Clathrin coats are
readily visible in ultrathin cryosections (Fig. 1, A–D; Fig. 3
B; Fig. 4 A). In the AP-3 and AP-1 double-labeled cells,
46.3 
 


 
 7.4% (average 
 


 
 SEM) of AP-3 was found on clath-
rin-coated membranes (as defined by the presence of a dense
cytosolic coat), whereas in these same cells 91 
 


 
 8.5% of
AP-1 label resided in coated membranes. Colocalization of
AP-3 and AP-1 onto a single membrane bud or vesicular
profile occurred to a very minor extent (
 

 
10%). We con-
clude from these data that AP-3 does localize with clathrin,
but to a lesser extent than does AP-1, and that AP-3 and AP-1
mediate different exits from a single endosomal tubule.
 
LAMP-1 and LAMP-2 are concentrated in AP-3 buds 
on endosomal tubules
 
So far, our data indicate a role for AP-3 in protein traffic from
the tubular recycling endosomes evolving from EEs. This was
surprising because previous reports had found no effect of
AP-3 deficiency on recycling proteins. Moreover, endosomal
tubules are not known to be involved in the delivery of lyso-
somal membrane proteins to the lysosomes. To address this
issue, we performed double labelings of AP-3 and LAMP-1 in
HepG2 cells (Fig. 4, A–C, E, and F). The vast majority of
LAMP-1 label was, as expected, found in the lysosomes (Fig.
4, E and F). LAMP-1 located in the TGN showed no colocal-
ization with AP-3 (Fig. 4 A). Importantly, low but consistent
amounts of LAMP-1 label were present in the AP-3–bearing
endosomal tubules (Fig. 4, B and C). LAMP-1 colocalized
with internalized Tf-biotin in EE vacuoles and in the sur-
rounding tubules, reinforcing the notion that LAMP-1 is
present in EE-associated tubules (Fig. 4 D). Finally, we per-
formed a triple labeling between AP-3, LAMP-1, and AS-
GPR. LAMP-1 was found together with ASGPR in the endo-
some-associated tubules labeled for AP-3 (Fig. 5).
During our experiments, we noticed that the labeling for
LAMP-1 was often found precisely in the AP-3–positive buds
emerging from the endosomal tubules (Fig. 4, A–C, E, and F;
Fig. 5, B and C). We then performed quantitative EM analy-
sis to establish the concentrations of LAMP-1, LAMP-2, CI-
MPR, and ASGPR in AP-3 budding profiles relative to that
in the continuous, associated membranes lacking AP-3 (Ta-
ble I; see Materials and methods for a more detailed descrip-
tion). Membranes in continuity with the AP-3–positive
membrane buds were divided in noncoated tubular regions
(Table I, column B) and AP-3–negative buds (Table I, col-
Figure 4. LAMP-1 is concentrated in AP-3–positive 
budding profiles. (A–C) Double labelings of AP-3 
(15-nm gold) and LAMP-1 (10-nm gold), showing 
colocalization in endosome (E)-associated tubular–
vesicular profiles (arrows). Low labeling densities 
of LAMP-1 are present in the AP-3–positive tubules. 
Note that in A, the LAMP-1/AP-3 positive tubule 
(arrow) has a smaller diameter than the typical 
TGN-associated clathrin-coated buds (arrowheads). 
(D) Colocalization of LAMP-1 (10-nm gold) and 
Tf-biotin internalized for 20 min (15-nm gold) 
unequivocally shows that LAMP-1 is present in 
EE-derived recycling tubules (arrows). (E and F) 
Double labelings of AP-3 (15-nm gold) and LAMP-1 
(10-nm gold), showing that LAMP-1 is found within 
the AP-3–positive regions of the endosome-derived 
tubules (arrows). EE, early endosome; G, Golgi 
complex; L, lysosome; M, mitochondrion; N, 
nucleous; P, plasma membrane. Bars, 200 nm.
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umn C), which amongst others will include the AP-1–coated
buds and AP-3–independent concentration sites such as is
shown for CI-MPR (Fig. 2, F and G). To measure the en-
richment for cargo proteins in AP-3–positive buds, we there-
fore divided the labeling density in the AP-3–positive buds by
that in the nonconcentrating, noncoated regions of the tu-
bule (Table I, column A/B). This clearly showed that LAMP-1
and LAMP-2 are concentrated in AP-3 buds over the at-
tached AP-3–negative membrane tubules, by factors of 8.5
and 3.6, respectively. By contrast, the ASGPR and CI-MPR
are not enriched in the AP-3–positive buds. These results
suggest that AP-3 plays a role in the segregation and concen-
tration of LAMP-1 and LAMP-2 (but not CI-MPR and AS-
GPR) within the tubular endosomal compartment.
 
Loss of AP-3 leads to increased levels of recycling of 
LAMP-1 and CD63 back to the cell surface
 
From our immuno-EM experiments, we would predict
that loss of AP-3 should lead to increased recycling of
LAMP-1 and CD63 via the cell surface due to the de-
creased efficiency of lysosomal delivery from the tubular
endosomes. To test this hypothesis, we decided to look at
the trafficking of both LAMP-1 and CD63 in AP-3–defi-
cient and rescued fibroblasts, using flow cytometry. Due to
the lack of an antibody against mouse CD63, a 
 
mocha
 
 cell
line was generated that expressed human CD63 at a similar
level to that of endogenous LAMP-1 (Fig. S2, available
at http://www.jcb.org/cgi/content/full/jcb.200311064/
DC1). This cell line was then subsequently infected with
either empty virus (Fig. 6 A, mock) or virus expressing the
 

 
 subunit of the AP-3 complex (Fig. 6 A, rescued). By im-
muno-EM, AP-3 in rescued 
 
mocha
 
 cells showed a similar
labeling pattern as in HepG2 cells (Fig. S3); AP-3 was
readily detected on endosome-associated tubules where it
colocalized with LAMP-1. Quantitation of LAMP-1 label-
ing density over AP-3–bearing tubules revealed a marked
concentration of LAMP-1 in the AP-3–positive buds (Ta-
ble I). Using the 
 
mocha
 
 cells as negative control, the rela-
tive distribution of AP-3 in rescued 
 
mocha
 
 cells was estab-
lished (Table II). This quantitative approach revealed low
 
Table I. 
 
Lysosomal membrane proteins are concentrated in AP-3–labeled regions of tubular sorting endosomes
Labeling density (gold/intersection)
(A)
AP-3
 
positive
 
(B)
AP-3
 
negative
 
 
(noncoated) 
(C)
AP-3
 
negative
 
 
(coated)
A/B
 
HepG2 LAMP-1 0.34 
 


 
 0.03 0.04 
 


 
 0.03 0.03 
 


 
 0.02 8.5
HepG2 LAMP-2 0.36 
 


 
 0.04 0.10 
 


 
 0.05 0.05 
 


 
 0.02 3.6
HepG2 CI-MPR 0.15 
 


 
 0.03 0.15 
 


 
 0.04 0.15 
 


 
 0.02 1.0
HepG2 ASGPR 0.13 
 


 
 0.03 0.14 
 


 
 0.07 0.16 
 


 
 0.02 0.9
Rescued 
 
mocha
 
LAMP-1 0.34 
 


 
 0.01 0.01 
 


 
 0.01 0.03 
 


 
 0.03 34
Numbers represent the labeling densities 
 


 
 SEM of the indicated cargo proteins in distinct regions of AP-3–positive compartments. Within AP-3–positive
membrane tubules, three membrane categories were discriminated: (A) AP-3–positive membrane buds and vesicles; (B) AP-3–negative, noncoated often
tubular membranes; and (C) AP-3–negative but visibly coated membrane buds. B and C were only defined when seen in continuity with A.
Figure 5. LAMP-1 concentrates in AP-3–coated 
buds on ASGPR-positive tubular endosomes. 
(A–C) HepG2 cells triple labeled for AP-3 
(15-nm gold), LAMP-1 (10-nm gold), and ASGPR 
(5-nm gold). In A, note the extensive network of 
endosome (E)-associated tubules (arrowhead) that 
labels positive for all three proteins. In B and C, 
the arrows point to AP-3–positive parts of the 
ASGPR-labeled tubules that contain LAMP-1. 
Bars, 200 nm.
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levels (4%) of staining in the TGN (defined as within 500
nm of the trans-side of a Golgi complex), whereas 43% of
the label was found on the characteristic tubular mem-
branes near endosomal vacuoles (Table II, Fig. S3). 40% of
the AP-3 label was associated with tubulo-vesicular profiles
that within the plain of the section were not in close vicin-
ity of an endosomal vacuole or the Golgi complex.
Notably, we found that the levels of LAMP-1 and CD63
were greatly increased on the cell surface in mock-trans-
fected cells (AP-3 deficient) compared with rescued 
 
mocha
 
cells (approximately eight- and fivefold, respectively; Fig. 6
B). Interestingly, the level of CD63 at the cell surface is far
greater than that of LAMP-1 both in mock and rescued
cells (Fig. 6 B and Fig. S2). In agreement with the steady-
state levels, the amount of LAMP-1 and CD63 delivered to
the cell surface is also greatly increased in mock compared
with rescued cells (Fig. 6 C; for triplicate experiments see
Fig. S4, available at http://www.jcb.org/cgi/content/full/
jcb.200311064/DC1). These data confirm previous re-
ports showing increased trafficking of LAMP-1 and CD63
over the plasma membrane of AP-3–deficient cells (Dell’An-
gelica et al., 1999), but do not discriminate between pro-
teins derived from the TGN or endosomes. To address this
point, we next looked at the levels of recycling of internal-
ized anti-TfR, anti-LAMP-1, and anti-CD63 antibodies
fed to the cells in a 20-min pulse (Fig. 7). No significant
difference was detected between TfR recycling in mock
and rescued cells. This result was confirmed by assaying Tf
recycling (unpublished data). However, in agreement with
the proposed role for AP-3 on tubular endosomes, we de-
tected a significant increase in antibody recycling for
LAMP-1 and CD63 in mock compared with rescued cells
(
 

 
1.8–3.3- and 1.7–2.1-fold increase, respectively; experi-
ments were performed in triplicate and similar results were
obtained and shown in Fig. S5).
 
Discussion
 
Despite significant progress in our understanding of AP-3
structure, function, and regulation, several important ques-
tions have remained unanswered: (1) the subcellular local-
ization of AP-3; (2) the transport step of lysosomal mem-
brane proteins that is mediated by AP-3; and (3) the
physiological significance of clathrin in AP-3–dependent
trafficking. In this work, we have generated an mAb
against the 
 

 
 subunit of AP-3 to localize the complex by
immuno-EM, and have studied the trafficking of lysosomal
membrane proteins in AP-3–deficient cells. Collectively,
our data reveal that the AP-3 complex marks a thus far un-
recognized exit site for lysosomal membrane proteins from
endosome-associated tubules.
 
Table II. 
 
Relative distribution (%) of AP-3 in rescued 
 
mocha
 
 cells
TGN Endosomal 
tubules/vesicles
Cytosolic 
tubules/vesicles
Endosomal vacuole Undefined
Limiting Lumenal
 
4 37 41 5 1 6
Numbers represent the percentages of total AP-3–representing gold particles that were found over the indicated compartments. The TGN was defined as
membranes 
 

 
500 nm at the trans-side of a Golgi complex. Endosomal tubules/vesicles include all membrane profiles 
 

 
200 nm from an endosomal vacuole. All
AP-3–labeled vesicular–tubular profiles not associated with a Golgi complex or endosome in the plane of the section were designated as cytosolic. The percentages
were calculated after correction for background labeling in 
 
mocha
 
 cells, and were based on the counting of 500 ad random encountered cell profiles.
Figure 6. AP-3 deficiency leads to increased levels of LAMP-1 and 
CD63 on the cell surface. mocha cells expressing human CD63 
were infected with either empty virus (mock) or virus expressing 
the  subunit of the AP-3 complex (rescued). (A) After selection, 
95% of the mocha cells was rescued. Bar, 30 m. (B) Mock 
and rescued cells were incubated with either anti-LAMP-1 or anti-
CD63 antibodies at 4	C. The steady-state levels of LAMP-1 and CD63 
at the cell surface are greatly increased in AP-3–deficient cells, as 
determined by flow cytometry. (C) Mock and rescued cells were 
incubated for 20 min with either anti-LAMP-1 or anti-CD63 
antibodies at 37	C. The delivery of LAMP-1 and CD63 to the 
cells surface is greatly decreased in rescued cells, as determined 
by flow cytometry. See also Fig. S3 (available at http://www.jcb.org/
cgi/content/full/jcb.200311064/DC1).
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First, we set out to address to what compartment (or
compartments) the AP-3 complex localizes in mamma-
lian cells. In HepG2 cells, AP-3 was typically found on
budding profiles emerging from endosomal tubules con-
taining internalized Tf-biotin and ASGPR, two classical
markers of the endosomal recycling pathway (Dautry-
Varsat et al., 1983; Geuze et al., 1983; Klausner et al.,
1983; Hopkins et al., 1994), and CI-MPR, which recy-
cles between endosomes and the TGN (Kornfeld and
Mellman, 1989). In addition, AP-3–bearing tubules con-
tained the lysosomal proteins LAMP-1 and LAMP-2 and
displayed distinct, small-sized AP-1–positive buds. AP-1
on endosomal tubules has been implicated in retrograde
transport of MPR46 and Shiga toxin B subunit to the
TGN (Mallard et al., 1998; Meyer et al., 2000), as well as
recycling of internalized Tf (Mallard et al., 1998; van
Dam and Stoorvogel, 2002). The presence of distinct
types of recycling proteins and the association of multiple
adaptor complexes suggest that from the AP-3–contain-
ing tubular endosomes, proteins are sorted to distinct
destinations in the cell. Therefore, the AP-3–positive
compartment is best referred to as tubular sorting endo-
some. A point of future interest will be to define the
physical and functional boundaries between the tubular
sorting endosome, vacuolar sorting endosomes, and tubu-
lar recycling endosomes.
Our quantitative analyses revealed that of the different
types of cargo proteins present in the tubular sorting endo-
somes, only LAMP-1 and LAMP-2 were concentrated in the
AP-3–positive buds and associated vesicular profiles (Table
I). By contrast, ASGPR and CI-MPR were equally distrib-
uted over the AP-3–bearing and nonlabeled regions of the
endosomal tubules. These findings imply that AP-3 on tu-
bular sorting endosomes mediates an exit specific for lysoso-
mal membrane proteins. Lysosomal membrane proteins may
reach EEs via a direct pathway from the TGN or by follow-
ing the constitutive secretory pathway to the cell surface and
subsequent endocytosis (for review see Peters and von Fig-
ura, 1994; Hunziker and Geuze, 1996; Rouille et al., 2000).
In rat hepatocytes, 45% of newly synthesized LAMP-2 and
at least 25% of LAMP-1 passes through EEs before it
reaches later compartments (Akasaki et al., 1995, 1996). A
first possible pathway to the lysosome is then by incorpora-
tion into the intra-endosomal vesicles that form by inward
budding of the limiting membrane, and this leads to the for-
mation of multivesicular bodies (reviewed by Geuze, 1998).
Sorting into intra-endosomal vesicles is an active, signal-
mediated event, whereas recycling from EEs back to the cell
surface can occur by default (Dunn et al., 1989; Jing et al.,
1990; Mayor et al., 1993; Verges et al., 1999; Sachse et al.,
2002). Lysosomal membrane proteins that are not sorted
into the intra-endosomal vesicles will enter the tubular sort-
ing endosomes. Our data suggest that from here a second,
AP-3–mediated sorting step to the lysosomes originates (see
Fig. 8 for a model). As suggested previously (Dell’Angelica
et al., 1999; Starcevic et al., 2002), the model in Fig. 8 also
accounts for the increased transport of lysosomal proteins
via the plasma membrane in AP-3–deficient cells. Specifi-
cally, if AP-3 deficiency impairs transport from tubular sort-
ing endosomes to lysosomes, it will lead to an increased
incorporation of lysosomal membrane proteins into the de-
fault recycling pathway to the plasma membrane. Indeed,
this was what we observed when we compared the level of
recycling of endocytosed LAMP-1 and CD63 to the plasma
membrane in AP-3–deficient and rescued fibroblasts, pro-
viding additional strong evidence that AP-3 acts on an endo-
somal compartment. Consistent with previous papers (Le
Borgne et al., 1998; Dell’Angelica et al., 1999), recycling of
the TfR was unaffected in the AP-3–deficient cells.
We do not suggest that the AP-3 pathway is the only
route to lysosomes. At least a portion of lysosomal mem-
brane proteins will reach the lysosomes via the intra-endoso-
mal vesicles (Geuze, 1998). In addition, although we do not
find a role for AP-3 in transport from the TGN to late en-
dosomes or lysosomes, there is compelling evidence that
Figure 7. AP-3 deficiency leads to the increased recycling of 
lysosomal membrane proteins via the cell surface. Mock and rescued 
cells were allowed to internalize antibodies against LAMP-1, CD63, 
and TfR for 20 min at 37	C. The cells were washed and the amount 
of recycling was determined by incubating the cells for various 
amounts of time at 37	C in the presence of quenching antibody 
(anti-Alexa® 488). The cells were then analyzed by flow cytometry. 
The degree of recycling of LAMP-1 and CD63 is greatly enhanced 
in AP-3–deficient cells (mock); however, recycling of the TfR is 
unaffected. See also Fig. S4 (available at http://www.jcb.org/cgi/
content/full/jcb.200311064/DC1).
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such a direct pathway does exist, possibly using another coat
complex (Rouille et al., 2000). An indication that there are
indeed many routes to the lysosome is highlighted in cells
that are deficient in both AP-1 and AP-3 because lysosomal
proteins still localize to the lysosomes (Reusch et al., 2002).
The efficiency by which a pathway is taken may differ be-
tween cells and may depend on the expression levels (Harter
and Mellman, 1992). In this respect, an interesting addi-
tional conclusion from the internalization and recycling as-
says in the rescued 
 
mocha
 
 cells (Fig. 6 and Fig. 7) is that
LAMP-1 and CD63 appear to use distinct pathways for
lysosomal delivery with different efficiencies, with more
CD63 trafficking over the plasma membrane. Moreover,
our assays showed that also in rescued 
 
mocha
 
 cells, LAMP-1
and CD63 recycle from endosomes to the plasma mem-
brane, as was previously suggested for LAMP-2 (Akasaki et
al., 1993) and avian LAMP-1 (Lippincott-Schwartz and
Fambrough, 1987). These observations suggest that lyso-
somal membrane proteins may require several passages
through EEs before they are sorted to the lysosomes.
A role for AP-3 in lysosomal membrane protein traffic
from tubular sorting endosomes is in agreement with pre-
vious immuno-EM data in PC12 and A431 cells (Dell’An-
gelica et al., 1998), and with the recent observation that in
AP-3–deficient cytotoxic T-lymphocytes, tubular endo-
somes elongate (Clark et al., 2003). Our observations are
in contrast to a previous immuno-EM experiment in NRK
cells by Simpson et al. (1996), showing that AP-3 labeling
is mainly associated with the TGN. However, some of the
localization experiments of Simpson et al. (1996) were
done in the presence of GTP
 
S, which can lead to the
mislocalization of coat complexes (Seaman et al., 1993).
By in vitro recruitment experiments in mocha cells in the
presence of GTPS, it was found that the AP-3 complex
indeed distributes to a more perinuclear location than nor-
mal (unpublished data). We defined the TGN as the
membrane network within 500 nm of the trans-side of
the Golgi stack (Geuze et al., 1985). Our quantitations in
rescued mocha cells revealed that 4% of total AP-3 label
was found on membranes that by this definition were
classified as TGN. 41% of the AP-3 label was found on
tubulo-vesicular membranes associated with endosomes,
whereas 40% of AP-3 label was not clearly associated with
either endosomes or TGN (indicated as cytoplasmic). The
majority of the cytoplasmic membranes is probably of en-
dosomal origin, but we cannot exclude that they include
peripheral TGN profiles as well (Puertollano et al., 2003;
Waguri et al., 2003). Therefore, it remains possible that
AP-3 does play a minor role in the trafficking of cargo
molecules from the TGN, as was also suggested by others
(Nishimura et al., 2002; Rous et al., 2002).
Another issue we addressed was the potential interaction
of the AP-3 complex with clathrin. The association of AP-3
with clathrin has been shown previously (Dell’Angelica et
al., 1998), but we provide here the first quantitative analysis
in direct comparison with a well-known clathrin-binding
adaptor, AP-1. We found in HepG2 cells 46% of AP-3–
positive membranes, and 91% of AP-1–positive membranes
were coated for clathrin as well. A previous work in neu-
roendocrine PC12 cells revealed that 65% of the AP-3–pos-
itive membranes labeled for clathrin (Dell’Angelica et al.,
1998), which is possibly explained by the fact that in these
cells, AP-3 is involved in clathrin-dependent formation of
synaptic vesicles from endosomes (Faundez et al., 1998).
Together, the data in PC12 and HepG2 cells indicate that
AP-3 uses clathrin in vivo, but that at steady state its associ-
ation with clathrin is significantly lower than that of AP-1.
Possibly, the interaction between AP-3 and clathrin is
weaker than that found with the other adaptor complexes.
This would also explain why the AP-3 complex is not
present in clathrin-coated vesicle preparations and why
clathrin is not readily immunoprecipitated with antibodies
against AP-3 (Simpson et al., 1996; unpublished data). Al-
ternatively or additionally, the assembly of an AP-3 clathrin
coat may be a relatively slow process, resulting in lower
steady-state levels of association. A third possible explana-
tion is that clathrin might play a facilitating rather than
obligatory role. Clearly, further analyses are required to dis-
tinguish between these possibilities.
Figure 8. Proposed role for AP-3 in the trafficking of lysosomal 
membrane proteins. Lysosomal membrane proteins reach EE vacuoles 
(or sorting endosomes) directly from the TGN or from an indirect 
pathway via the plasma membrane. Proteins that are not incorporated 
into the internal endosomal vesicles will by default enter the tubular 
extensions that emerge from the endosomal vacuole. The default 
pathway from the tubular endosomes is to the plasma membrane, 
but there is also an AP-1– and AP-3–mediated exit. The AP-3–
containing membranes selectively concentrate lysosomal membrane 
proteins rather than proteins destined for TGN or plasma membrane, 
thus we propose they mediate transport to late endosomes/lysosomes. 
In this model, if AP-3 function were impaired, it would lead to an 
increased incorporation of lysosomal membrane proteins in the 
default recycling pathway, resulting in increased passage of lyso-
somal membrane proteins over the plasma membrane. E, early 
endosome; LE, late endosome; LYS, lysosome; PM, plasma membrane.
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Materials and methods
Antibody reagents
Mouse mAbs against the AP-3  subunit were generated by immunizing fe-
male BALB/c mice with a GST fusion protein corresponding to the hinge
domain of the  subunit (aa 608–800 of human -adaptin). Fusion of the
spleen cells with myeloma cells and screening of the resulting antibodies
was performed as described by Bock et al. (1997). Clones that yielded an
immunofluorescence pattern identical to that of an anti- polyclonal (Simp-
son et al., 1997; a gift from Dr. M.S. Robinson, University of Cambridge,
Cambridge, UK) were further characterized by immuno-EM. The clone
SA4 gave the most intense labeling, so it was used for all the immuno-EM
experiments performed in this paper. The SA4 cell line and resultant anti-
bodies are available from the Developmental Studies Hybridoma Bank
(University of Iowa, Iowa City, IA). The following polyclonal antibodies
were generously donated to us: anti-AP-1 (Dr. M. Robinson, University of
Cambridge, Cambridge, UK); antibody 931B against human LAMP-1 and
antibody 932.1 against human LAMP-2 (Dr. M. Fukuda, La Jolla Cancer
Research Foundation, La Jolla, CA); anti–mouse lgp120/LAMP-1 (Dr. I.
Mellman, Yale University, New Haven, CT); anti-CI-MPR (Dr. K. von Fig-
ura, University of Göttingen, Göttingen, Germany); antibody K1 against
the ASGPR (Dr. A. Schwartz, Washington University, St. Louis, MO); and
anti-clathrin (Dr. S. Corvera, University of Massachusetts Medical School,
Worcester, MA). Anti-biotin 100-4198 was obtained from Rockland Immu-
nochemicals. To compare the degree of colocalization of AP-3 and clath-
rin with that of AP-1 and clathrin, an mAb from Dr. E. Ungewickell (Medi-
cal University Hannover, Hannover, Germany) was used instead of the
polyclonal anti-AP-1. As a bridging step between mouse mAbs and protein
A–gold, we used rabbit anti–mouse (DakoCytomation). The hybridoma
cell lines 1D4B (rat anti–mouse LAMP-1; Hughes and August, 1981) and
H5C6 (mouse anti–human CD63) were obtained from the Developmental
Studies Hybridoma Bank, developed under the auspice of the National In-
stitute of Child Health and Human Development and maintained by the
University of Iowa (Department of Biological Sciences, Iowa City, IA). The
cell line TIB219 (rat anti–mouse TfR; Lesley et al., 1984) was obtained
from the American Type Culture Collection. All three antibodies were pu-
rified from the culture media using an anti–rat or anti–mouse affinity col-
umn, acid eluted, and conjugated to Alexa Fluor® 488 or 594 using a pro-
tein-labeling kit according to the manufacturer’s instructions (Molecular
Probes, Inc.).
Flow cytometry
A quantitative assay for AP-3–dependent sorting was used as described by
Peden et al. (2002), with the modifications listed below. Cells were
trypsinized, washed in complete medium, and incubated with Alexa®
488–conjugated anti-LAMP-1 and anti-CD63 antibodies (2 g/ml) for 30
min at 4	C. After shifting to 37	C for various times, the antibody binding
was stopped by pelleting the cells and resuspending them in 3% formalde-
hyde. To determine the amount of recycling of LAMP-1, CD63, and TfR,
cells were allowed to internalize labeled antibodies for 20 min, after
which excess antibodies were washed away with ice-cold DME. The cells
were then incubated with 24 g/ml quenching antibody (anti-Alexa® 488;
Molecular Probes, Inc.) in DME at 37	C for various times. To ensure com-
plete quenching, the cells were placed on ice for 30 min before being
fixed in 3% formaldehyde. The cells were analyzed using a flow cytometer
(Epics-Xl; Beckman Coulter).
Retroviral infections
The AP-3 -subunit–deficient mocha cell line (CRL-2709; American Type
Culture Collection), previously described by Peden et al. (2002), was in-
fected with virus expressing human CD63, followed by infection with the
wild-type  subunit of the AP-3 complex or empty virus as described by
Swift et al. (1999). The virus used was a version of pBMN modified such
that the hygromycin selectable marker was expressed on the same tran-
script as the  or CD63 messages. Infected cells were selected in 200 g/
ml hygromycin B.
Internalization of Tf-biotin and BSA-gold
Tf-biotin was obtained from Sigma-Aldrich and was iron saturated as de-
scribed previously (Stoorvogel et al., 1987). HepG2 cells cultured in 6-cm-
diam dishes were preincubated in MEM plus 0.1% BSA in a CO2 incubator
at 37	C, and then 20 g/ml Tf-biotin was added and allowed to internalize
for 20 min. Cells were rinsed twice with MEM containing 0.1% BSA at 4	C
and fixed overnight in a final concentration of 4% formaldehyde in 0.1 M
phosphate buffer, pH 7.4. BSA conjugated to 5 nm colloidal gold (final OD
of 5 at 520 nm) after overnight dialysis with serum-free media was similarly
used to mark the endocytic pathway, except the internalization was for 60
min in 1.5 ml MEM containing 1% FCS and 100 l BSA 5-nm gold.
Immuno-EM
Cells were fixed by adding 4% freshly prepared formaldehyde in 0.1 M
phosphate buffer, pH 7.4, to an equal volume of culture medium for 10
min, followed by post-fixation in 4% formaldehyde without medium, and
were stored at 4	C. Glutaraldehyde was found to strongly reduce the AP-3
labeling. Processing of cells for ultrathin cryosectioning and immunolabel-
ing according to the protein A–gold method was done as described previ-
ously (Slot et al., 1991; Liou et al., 1996).
To measure the diameter of AP-3– and AP-1–labeled budding profiles,
pictures of positively labeled membranes were randomly taken at a magni-
fication of 30,000 in the EM and used at an end magnification of 81,000.
The diameter of a labeled bud was measured with a ruler, after which the
data were recalculated to nanometers. For these countings, we did not in-
clude vesicular profiles nor the long AP-1/clathrin stretches found on the
TGN. We focused on buds clearly connected to TGN or endosomes.
To measure the degree of colocalization of AP-3 and AP-1 with clath-
rin, HepG2 cells were double labeled for AP-3 (15-nm gold) and AP-1
(10-nm gold). By moving randomly through the grid, for each AP-3– or
AP-1–representing gold particle it was established whether it was present
on a membrane bearing a visible clathrin coat. In total, 380 and 341 gold
particles were counted for AP-3 and AP-1, respectively, in three indepen-
dent experiments.
The labeling densities of CI-MPR, ASGPR, LAMP-1, and LAMP-2 were
established in series of double-labeling experiments in which AP-3 was
always used in the first step. AP-3–positive membranes were selected in
the EM and photographed only when they were also positive for the
marker protein under analysis. Per marker protein, at least 50 pictures
were taken at a magnification of 30,000 and were analyzed at an end
magnification of 81,000. The pictures were overlaid with a transparent
5-mm spaced line lattice. The number of gold particles present on AP-3–
positive and AP-3–negative regions of the compartments were counted,
as well as the number of intersections of the distinct membrane domains
with the 5-mm line lattice overlay, to give a measure of membrane length
(Weibel, 1979). The labeling density was then expressed as number of
gold particles per intersection, which reflects the concentration of a
given protein in a membrane domain.
The relative distribution of AP-3 in rescued mocha cells was assessed by
analyzing 500 ad random sampled cell profiles from two distinct grids. All
gold particles that were no further than 25 nm from a membrane were as-
cribed to the compartment on which they were found. This resulted in a
total of 555 gold particles over the relevant intracellular compartments. A
similar analysis in mocha cells (prepared and labeled in the same experi-
ment as the rescued mochas) yielded 74 gold particles, representing non-
specific background. After subtracting the background label over the dis-
tinct compartments from the specific label, the percentage of total label
over a given compartment in rescued mocha cells was calculated (Table
II). All tubulo-vesicular membranes within 200 nm from an endosomal
vacuole were designated as being endosome associated, whereas mem-
branes within 500 nm of the trans-side of a Golgi complex were desig-
nated TGN. Tubulo-vesicular membranes that in the plane of the section
were not associated with Golgi or endosomes were designated as cytoplas-
mic. All pictures were taken on a transmission electron microscope (model
1010; JEOL USA, Inc.).
Immunofluorescence
Cells were cultured on multiwell slides (ICN Biomedicals), fixed for 15 min
with 3% PFA in PBS, quenched for 10 min with 0.1 M glycine in PBS, per-
meabilized with 0.4% saponin in PBS for 10 min, and were then stained
with the primary antibody for 30 min. After incubation with secondary an-
tibody conjugated to Alexa® 488 or 594 for 20 min, coverslips were
mounted onto the cells with Vectashield® (Vector Laboratories). Images
were acquired using a microscope (Axiovert 200; Carl Zeiss MicroImaging,
Inc.) fitted with a Plan-Apochromat 1.4 NA 63 objective, a camera (Ax-
ioCam; Carl Zeiss MicroImaging, Inc.), and a Quad pass filter set (Chroma
Technology Corp.), all controlled by AxioVison 3.1 software (Carl Zeiss
MicroImaging, Inc.). The brightness and contrast of acquired images was
adjusted using Adobe Photoshop® v6.0.
Online supplemental material
Fig. S1 shows the characterization of mAb SA4 against the  subunit of
AP-3 that was used in this work. Fig. S2 shows the fluorescence staining of
LAMP-1 and CD63 in mock-transfected and rescued mocha cells. Fig. S3
shows the colocalization of AP-3 and LAMP-1 in endosomal tubules of res-
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cued mocha cells. Fig. S4 and Fig. S5 show the triplicates of the antibody
binding and recycling assays described in Fig. 6 and Fig. 7, respectively.
Online supplemental material available at http://www.jcb.org/cgi/content/
full/jcb.200311064/DC1.
We thank Martin Sachse for assistance with the BSA-gold and Tf-biotin up-
take experiments; Rene Scriwanek and Marc van Peski for the preparation
of the electron micrographs; members of the Scheller and Klumperman
labs for help and advice; S.J. Scales and H. Geuze for stimulating discus-
sions; M. Robinson for numerous reagents and helpful discussions; M.
Fukuda, K. von Figura, A. Schwartz, S. Corvera, E. Ungewickell, and I.
Mellman for their gifts of antibodies; Kurt Schroder for the purification of
antibodies; and Peter Schow for advice on flow cytometry.
Initially, A.A. Peden was supported by a grant from the Wellcome trust.
Submitted: 18 November 2003
Accepted: 13 February 2004
References
Akasaki, K., M. Fukuzawa, H. Kinoshita, K. Furuno, and H. Tsuji. 1993. Cycling
of two endogenous lysosomal membrane proteins, lamp-2 and acid phos-
phatase, between the cell surface and lysosomes in cultured rat hepatocytes.
J. Biochem. (Tokyo). 114:598–604.
Akasaki, K., A. Michihara, K. Mibuka, Y. Fujiwara, and H. Tsuji. 1995. Biosyn-
thetic transport of a major lysosomal membrane glycoprotein, lamp-1: con-
vergence of biosynthetic and endocytic pathways occurs at three distinctive
points. Exp. Cell Res. 220:464–473.
Akasaki, K., A. Michihara, Y. Fujiwara, K. Mibuka, and H. Tsuji. 1996. Biosyn-
thetic transport of a major lysosome-associated membrane glycoprotein 2,
lamp-2: a significant fraction of newly synthesized lamp-2 is delivered to ly-
sosomes by way of early endosomes. J. Biochem. (Tokyo). 120:1088–1094.
Bock, J.B., J. Klumperman, S. Davanger, and R.H. Scheller. 1997. Syntaxin 6
functions in trans-Golgi network vesicle trafficking. Mol. Biol. Cell. 8:1261–
1271.
Clark, R.H., J.C. Stinchcombe, A. Day, E. Blott, S. Booth, G. Bossi, T. Hamblin,
E.G. Davies, and G.M. Griffiths. 2003. Adaptor protein 3-dependent mi-
crotubule-mediated movement of lytic granules to the immunological syn-
apse. Nat. Immunol. 4:1111–1120.
Cowles, C.R., G. Odorizzi, G.S. Payne, and S.D. Emr. 1997. The AP-3 adaptor
complex is essential for cargo-selective transport to the yeast vacuole. Cell.
91:109–118.
Dautry-Varsat, A., A. Ciechanover, and H.F. Lodish. 1983. pH and the recycling
of transferrin during receptor-mediated endocytosis. Proc. Natl. Acad. Sci.
USA. 80:2258–2262.
Dell’Angelica, E.C., H. Ohno, C.E. Ooi, E. Rabinovich, K.W. Roche, and J.S.
Bonifacino. 1997. AP-3: an adaptor-like protein complex with ubiquitous
expression. EMBO J. 16:917–928.
Dell’Angelica, E.C., J. Klumperman, W. Stoorvogel, and J.S. Bonifacino. 1998.
Association of the AP-3 adaptor complex with clathrin. Science. 280:431–
434.
Dell’Angelica, E.C., V. Shotelersuk, R.C. Aguilar, W.A. Gahl, and J.S. Bonifacino.
1999. Altered trafficking of lysosomal proteins in Hermansky-Pudlak syn-
drome due to mutations in the 3A-subunit of the AP-3 adaptor. Mol. Cell.
3:11–21.
Doray, B., P. Ghosh, J. Griffith, H.J. Geuze, and S. Kornfeld. 2002. Cooperation
of GGAs and AP-1 in packaging MPRs at the trans-Golgi network. Science.
297:1700–1703.
Drake, M.T., Y. Zhu, and S. Kornfeld. 2000. The assembly of AP-3 adaptor com-
plex-containing clathrin-coated vesicles on synthetic liposomes. Mol. Biol.
Cell. 11:3723–3736.
Dunn, K.W., T.E. McGraw, and F.R. Maxfield. 1989. Iterative fractionation of re-
cycling receptors from lysosomally destined ligands in an early sorting endo-
some. J. Cell Biol. 109:3303–3314.
Faundez, V., J.T. Horng, and R.B. Kelly. 1998. A function for the AP3 coat com-
plex in synaptic vesicle formation from endosomes. Cell. 93:423–432.
Geuze, H.J. 1998. The role of endosomes and lysosomes in MHC class II function-
ing. Immunol. Today. 19:282–287.
Geuze, H.J., J.W. Slot, G.J. Strous, H.F. Lodish, and A.L. Schwartz. 1983. Intra-
cellular site of asialoglycoprotein receptor-ligand uncoupling: double-label
immunoelectron microscopy during receptor-mediated endocytosis. Cell.
32:277–287.
Geuze, H.J., J.W. Slot, G.J. Strous, A. Hasilik, and K. von Figura. 1985. Possible
pathways for lysosomal enzyme delivery. J. Cell Biol. 101:2253–2262.
Griffiths, G., R. Back, and M. Marsh. 1989. A quantitative analysis of the en-
docytic pathway in baby hamster kidney cells. J. Cell Biol. 109:2703–2720.
Harter, C., and I. Mellman. 1992. Transport of the lysosomal membrane glycopro-
tein lgp120 (lgpA) to lysosomes does not require appearance on the plasma
membrane. J. Cell Biol. 117:311–325.
Heuser, J.E., and J. Keen. 1988. Deep-etch visualization of proteins involved in
clathrin assembly. J. Cell Biol. 107:877–886.
Hopkins, C.R., A. Gibson, M. Shipman, D.K. Strickland, and I.S. Trowbridge.
1994. In migrating fibroblasts, recycling receptors are concentrated in nar-
row tubules in the pericentriolar area, and then routed to the plasma mem-
brane of the leading lamella. J. Cell Biol. 125:1265–1274.
Hughes, E.N., and J.T. August. 1981. Characterization of plasma membrane pro-
teins identified by monoclonal antibodies. J. Biol. Chem. 256:664–671.
Hunziker, W., and H.J. Geuze. 1996. Intracellular trafficking of lysosomal mem-
brane proteins. Bioessays. 18:379–389.
Jing, S.Q., T. Spencer, K. Miller, C. Hopkins, and I.S. Trowbridge. 1990. Role of
the human transferrin receptor cytoplasmic domain in endocytosis: localiza-
tion of a specific signal sequence for internalization. J. Cell Biol. 110:283–294.
Klausner, R.D., G. Ashwell, J. van Renswoude, J.B. Harford, and K.R. Bridges.
1983. Binding of apotransferrin to K562 cells: explanation of the transferrin
cycle. Proc. Natl. Acad. Sci. USA. 80:2263–2266.
Klumperman, J., A. Hille, T. Veenendaal, V. Oorschot, W. Stoorvogel, K. von Fig-
ura, and H.J. Geuze. 1993. Differences in the endosomal distributions of the
two mannose 6-phosphate receptors. J. Cell Biol. 121:997–1010.
Kornfeld, S., and I. Mellman. 1989. The biogenesis of lysosomes. Annu. Rev. Cell
Biol. 5:483–525.
Le Borgne, R., A. Alconada, U. Bauer, and B. Hoflack. 1998. The mammalian
AP-3 adaptor-like complex mediates the intracellular transport of lysosomal
membrane glycoproteins. J. Biol. Chem. 273:29451–29461.
Lesley, J., R. Hyman, R. Schulte, and J. Trotter. 1984. Expression of transferrin re-
ceptor on murine hematopoietic progenitors. Cell. Immunol. 83:14–25.
Liou, W., H.J. Geuze, and J.W. Slot. 1996. Improving structural integrity of cryo-
sections for immunogold labeling. Histochem. Cell Biol. 106:41–58.
Lippincott-Schwartz, J., and D.M. Fambrough. 1987. Cycling of the integral
membrane glycoprotein, LEP100, between plasma membrane and lyso-
somes: kinetic and morphological analysis. Cell. 49:669–677.
Mallard, F., C. Antony, D. Tenza, J. Salamero, B. Goud, and L. Johannes. 1998.
Direct pathway from early/recycling endosomes to the Golgi apparatus re-
vealed through the study of shiga toxin B-fragment transport. J. Cell Biol.
143:973–990.
Marsh, M., G. Griffiths, G.E. Dean, I. Mellman, and A. Helenius. 1986. Three-
dimensional structure of endosomes in BHK-21 cells. Proc. Natl. Acad. Sci.
USA. 83:2899–2903.
Mayor, S., J.F. Presley, and F.R. Maxfield. 1993. Sorting of membrane compo-
nents from endosomes and subsequent recycling to the cell surface occurs by
a bulk flow process. J. Cell Biol. 121:1257–1269.
Meyer, C., D. Zizioli, S. Lausmann, E.L. Eskelinen, J. Hamann, P. Saftig, K. von
Figura, and P. Schu. 2000. 1A adaptin-deficient mice: lethality, loss of
AP-1 binding and rerouting of mannose 6-phosphate receptors. EMBO J.
19:2193–2203.
Nishimura, N., H. Plutner, K. Hahn, and W.E. Balch. 2002. The  subunit of
AP-3 is required for efficient transport of VSV-G from the trans-Golgi net-
work to the cell surface. Proc. Natl. Acad. Sci. USA. 99:6755–6760.
Odorizzi, G., C.R. Cowles, and S.D. Emr. 1998. The AP-3 complex: a coat of
many colours. Trends Cell Biol. 8:282–288.
Peden, A.A., R.E. Rudge, W.W. Lui, and M.S. Robinson. 2002. Assembly and
function of AP-3 complexes in cells expressing mutant-subunits. J. Cell Biol.
156:327–336.
Peters, C., and K. von Figura. 1994. Biogenesis of lysosomal membranes. FEBS
Lett. 346:108–114.
Puertollano, R., N.N. van der Wel, L.E. Greene, E. Eisenberg, P.J. Peters, and J.S.
Bonifacino. 2003. Morphology and dynamics of clathrin/GGA1-coated car-
riers budding from the trans-Golgi network. Mol. Biol. Cell. 14:1545–1557.
Reusch, U., O. Bernhard, U. Koszinowski, and P. Schu. 2002. AP-1A and AP-3A
lysosomal sorting functions. Traffic. 3:752–761.
Robinson, M.S., and J.S. Bonifacino. 2001. Adaptor-related proteins. Curr. Opin.
Cell Biol. 13:444–453.
Rouille, Y., W. Rohn, and B. Hoflack. 2000. Targeting of lysosomal proteins.
Semin. Cell Dev. Biol. 11:165–171.
Rous, B.A., B.J. Reaves, G. Ihrke, J.A. Briggs, S.R. Gray, D.J. Stephens, G.
1076 The Journal of Cell Biology | Volume 164, Number 7, 2004
Banting, and J.P. Luzio. 2002. Role of adaptor complex AP-3 in targeting
wild-type and mutated CD63 to lysosomes. Mol. Biol. Cell. 13:1071–1082.
Sachse, M., S. Urbe, V. Oorschot, G.J. Strous, and J. Klumperman. 2002. Bilay-
ered clathrin coats on endosomal vacuoles are involved in protein sorting to-
ward lysosomes. Mol. Biol. Cell. 13:1313–1328.
Seaman, M.N., C.L. Ball, and M.S. Robinson. 1993. Targeting and mistargeting
of plasma membrane adaptors in vitro. J. Cell Biol. 123:1093–1105.
Simpson, F., N.A. Bright, M.A. West, L.S. Newman, R.B. Darnell, and M.S. Rob-
inson. 1996. A novel adaptor-related protein complex. J. Cell Biol. 133:749–
760.
Simpson, F., A.A. Peden, L. Christopoulou, and M.S. Robinson. 1997. Character-
ization of the adaptor-related protein complex, AP-3. J. Cell Biol. 137:835–
845.
Slot, J.W., H.J. Geuze, S. Gigengack, G.E. Lienhard, and D.E. James. 1991. Im-
muno-localization of the insulin regulatable glucose transporter in brown
adipose tissue of the rat. J. Cell Biol. 113:123–135.
Starcevic, M., R. Nazarian, and E.C. Dell’Angelica. 2002. The molecular machin-
ery for the biogenesis of lysosome-related organelles: lessons from Herman-
sky-Pudlak syndrome. Semin. Cell Dev. Biol. 13:271–278.
Stepp, J.D., K. Huang, and S.K. Lemmon. 1997. The yeast adaptor protein com-
plex, AP-3, is essential for the efficient delivery of alkaline phosphatase by
the alternate pathway to the vacuole. J. Cell Biol. 139:1761–1774.
Stoorvogel, W., H.J. Geuze, and G.J. Strous. 1987. Sorting of endocytosed trans-
ferrin and asialoglycoprotein occurs immediately after internalization in
HepG2 cells. J. Cell Biol. 104:1261–1268.
Sugita, M., X. Cao, G.F. Watts, R.A. Rogers, J.S. Bonifacino, and M.B. Brenner.
2002. Failure of trafficking and antigen presentation by CD1 in AP-3-defi-
cient cells. Immunity. 16:697–706.
Swift, S., J.B. Lorens, P. Achacoso, and G.P. Nolan. 1999. Rapid production of
retroviruses for efficient gene delivery to mammalian cells using 293T cell-
based systems. In Current Protocols in Immunology. J.E. Coligan, A.M.
Kruisbeek, D.H. Margulies, E.M. Shevach, and W. Strober, editors. John
Wiley & Sons Inc., New York. Suppl. 31.
ter Haar, E., S.C. Harrison, and T. Kirchhausen. 2000. Peptide-in-groove interac-
tions link target proteins to the -propeller of clathrin. Proc. Natl. Acad. Sci.
USA. 97:1096–1100.
van Dam, E.M., and W. Stoorvogel. 2002. Dynamin-dependent transferrin recep-
tor recycling by endosome-derived clathrin-coated vesicles. Mol. Biol. Cell.
13:169–182.
Verges, M., R.J. Havel, and K.E. Mostov. 1999. A tubular endosomal fraction
from rat liver: biochemical evidence of receptor sorting by default. Proc.
Natl. Acad. Sci. USA. 96:10146–10151.
Vowels, J.J., and G.S. Payne. 1998. A dileucine-like sorting signal directs transport
into an AP-3-dependent, clathrin-independent pathway to the yeast vacuole.
EMBO J. 17:2482–2493.
Waguri, S., F. Dewitte, R. Le Borgne, Y. Rouille, Y. Uchiyama, J.F. Dubremetz,
and B. Hoflack. 2003. Visualization of TGN to endosome trafficking
through fluorescently labeled MPR and AP-1 in living cells. Mol. Biol. Cell.
14:142–155.
Weibel, E.R. 1979. Stereological Methods: Practical Methods for Biological Mor-
phometry. Vol. 1. Academic Press, London/New York. 415 pp.
Wettey, F.R., S.F. Hawkins, A. Stewart, J.P. Luzio, J.C. Howard, and A.P. Jack-
son. 2002. Controlled elimination of clathrin heavy-chain expression in
DT40 lymphocytes. Science. 297:1521–1525.
